Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Research & Development: 2018-2020

Historic Research & Development for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to -$364.4 million.

  • Genmab A's Research & Development fell 36.40% to -$100.70 in Q2 2021 from the same period last year, while for Jun 2021 it was -$321.51, marking a year-over-year decrease of 100.00%. This contributed to the annual value of -$364.4 million for FY2020, which is 46.87% down from last year.
  • According to the latest figures from FY2020, Genmab A's Research & Development is -$364.4 million, which was down 46.87% from -$248.1 million recorded in FY2019.
  • Over the past 5 years, Genmab A's Research & Development peaked at -$158.2 million during FY2018, and registered a low of -$364.4 million during FY2020.
  • For the 3-year period, Genmab A's Research & Development averaged around -$256.9 million, with its median value being -$248.1 million (2019).
  • Data for Genmab A's Research & Development shows a maximum YoY crashed of 56.83% (in 2019) over the last 5 years.
  • Over the past 3 years, Genmab A's Research & Development (Yearly) stood at -$158.2 million in 2018, then tumbled by 56.83% to -$248.1 million in 2019, then crashed by 46.87% to -$364.4 million in 2020.